None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Children between 6 years to 14 years fulfilling the criteria for Migraine according to ICHD-3
Exclusion criteria
Exclusion criteria: Children with headache due to some known secondary causes like infection, refractive error Children with known comorbidities like chronic renal, liver, heart and GIT diseases Any previous known allergies to probiotics, such as allergic reactions to probiotic products or a compromised immune system (due to cancer treatment, immunosuppressive therapy)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is the reduction in the number of headache episodes post-treatmentTimepoint: The outcome will be measured at 4 weeks and 8 weeks post treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Change in pain severity scores (Wong-Baker Scale). 2.Frequency of analgesic use during the study period. 3.Treatment adherence & any reported side effects 4. see the adherence & adverse effects of probiotics Timepoint: assessed at 4 weeks & 8 weeks of treatment | — |
Countries
India
Contacts
AIIMS Mangalagiri